Huntington Disease
📧 Sign up to get email alerts when something new happens for Huntington Disease.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2026-01-09EMA Application withdrawn: Nurzigma (pridopidine hydrochloride) — Prilenia Therapeutics B.V.
EMA has withdrawn the application for Nurzigma (pridopidine hydrochloride) by Prilenia Therapeutics B.V. for Huntington disease.
-
CLINICAL_TRIALS withdrawal · 2017-05-05Clinical Trial Update: Characterization of the Profile of Dysarthria in Huntington's Disease, Using the Clinical Evaluation Battery of Dysarthria [NA]
A clinical trial update noting the withdrawal of NCT03142217, a study characterizing dysarthria in Huntington's disease conducted by Centre …
-
CLINICAL_TRIALS withdrawal · 2012-11-06Clinical Trial Update: Treating Sleep/Wake Cycle Disturbances in Basal Ganglia Disorders With Ramelteon [NA]
The ramelteon trial for sleep/wake disturbances in basal ganglia disorders has been withdrawn, involving Huntington's disease and Parkinson'…